article

Mass Spectrometry In-Depth Focus 2012

In this free to view Mass Spectrometry In-Depth Focus: Mass spectrometry in drug discovery – Proteomics, small molecules and metablomics; Quantification of membrane drug transporters and application in drug discovery and development; Mass spectrometry leaders roundtable…

Mass Spectrometry supplement 2012
  • Mass spectrometry in drug discovery – Proteomics, small molecules and metablomics
    Ana Rita Angelino and Min Yang, Department of Pharmaceutical and Biological Chemistry, UCL School of Pharmacy
  • Quantification of membrane drug transporters and application in drug discovery and development
    Tasso Miliotis and Constanze Hilgendorf, Innovative Medicines, AstraZeneca R&D
  • Show preview – The 60th annual conference on Mass Spectrometry and Allied Topics
  • Anthony Bristow, AstraZeneca, poses the questions for our Mass Spectrometry Leaders Roundtable
    George McLeod, Market Manager, Pharmaceutical MS, Bruker Daltonics / Detlev Hochmuth, Scientific Consultant and Software Developer for MS and Chemoinformatics, Dr. Hochmuth Scientific Consulting / Alessandro Baldi, VP & General Manager, Protea Biosciences Inc / Gary Harland, Mass Spectrometry Product Manager, Waters Corporation

This Mass Spectrometry In-Depth Focus is restricted - login or subscribe free to access

EPR Issue 1 2024Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • bi-monthly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here